Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced B Cell Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01628471
What this trial is testing

MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Uman Pharma 20
Early research (Phase 1)Study completedNCT01607892
What this trial is testing

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

Who this might be right for
Hematological Malignancies
Karyopharm Therapeutics Inc 286
Early research (Phase 1)Study completedNCT00301951
What this trial is testing

Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of California, San Francisco 7
Early research (Phase 1)Study completedNCT00003331
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
NYU Langone Health 30
Early research (Phase 1)Study completedNCT03010982
What this trial is testing

Open-Label, Multi-Center, Two-Part, Ph1 Study to Characterize the PKs of an Intravenous Micro-Dose of [14C]-Tazemetostat (EPZ 6438) and the ADME of an Oral [14C]-Labeled Dose of Tazemetostat in Subjects With B-Cell Lymphomas or Adv Solid Tumors

Who this might be right for
Diffuse Large B Cell LymphomaPrimary Mediastinal LymphomaMantle-Cell Lymphoma+3 more
Epizyme, Inc. 3
Early research (Phase 1)Study completedNCT03082209
What this trial is testing

The Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies

Who this might be right for
Advanced Solid TumorsCancerHematologic Malignancies
AbbVie 153
Early research (Phase 1)Study completedNCT01164709
What this trial is testing

Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMature T-cell and Nk-cell Neoplasms+1 more
Swiss Cancer Institute 18
Early research (Phase 1)Looking for participantsNCT07195916
What this trial is testing

Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Solid TumorsHematologic Malignancies
Incyte Corporation 280
Testing effectiveness (Phase 2)Looking for participantsNCT04329728
What this trial is testing

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Who this might be right for
Lymphoid Malignancies
AVM Biotechnology Inc 144
Early research (Phase 1)Study completedNCT00088868
What this trial is testing

17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 40
Early research (Phase 1)Study completedNCT01497184
What this trial is testing

Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 95
Post-approval studies (Phase 4)Looking for participantsNCT07426484
What this trial is testing

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Who this might be right for
Cutaneous Squamous Cell CarcinomaSkin Cancer
Dana-Farber Cancer Institute 80
Early research (Phase 1)Study completedNCT03922204
What this trial is testing

Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

Who this might be right for
Advanced CancerSolid Tumor, AdultB-cell Lymphoma, Adult
Merus B.V. 72
Early research (Phase 1)Looking for participantsNCT06615193
What this trial is testing

HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor

Who this might be right for
Advanced Solid TumorsRefractory LymphomaRelapsed Hematologic Malignancy
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 111
Early research (Phase 1)Study completedNCT00089271
What this trial is testing

17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas

Who this might be right for
Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+47 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT01353625
What this trial is testing

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

Who this might be right for
Glioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more
Celgene 118
Early research (Phase 1)Study completedNCT00396864
What this trial is testing

Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma

Who this might be right for
CancerLymphomas
Celgene 51
Early research (Phase 1)Looking for participantsNCT07603479
What this trial is testing

JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Who this might be right for
MalignanciesSolid Malignant TumorNHL (Non-Hodgkin Lymphoma)+1 more
Jecho Biopharmaceuticals Co., Ltd. 14
Testing effectiveness (Phase 2)Study completedNCT00743379
What this trial is testing

Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerProstate CancerPancreatic Cancer
Threshold Pharmaceuticals 71
Testing effectiveness (Phase 2)Study completedNCT00983619
What this trial is testing

A Clinical Study Using MEDI-551 in Adult Participants With Relapsed or Refractory Advanced B-Cell Malignancies

Who this might be right for
B-cell MalignanciesCancer
MedImmune LLC 136
Next Page